Aptamers Market by Applications & Technology – 2018 - PowerPoint PPT Presentation

About This Presentation
Title:

Aptamers Market by Applications & Technology – 2018

Description:

The global aptamers market was valued at $200 million in the year 2012. At the end of 2013, the market is expected to be $287 million and is poised to reach approximately $2.1 billion by 2018, growing at a CAGR of 49.24% from 2013 to 2018. – PowerPoint PPT presentation

Number of Views:121

less

Transcript and Presenter's Notes

Title: Aptamers Market by Applications & Technology – 2018


1
MarketsandMarkets Presents
Aptamers Market worth 2.1 Billion By 2018
http//www.marketsandmarkets.com/Market-Reports/ap
tamers-technology-market-1167.html
2
The "Aptamers Market - Technology Trend Analysis
By Applications - Therapeutics, Diagnostics,
Biosensors, Drug Discovery, Biomarker Discovery,
Research Applications with Market Landscape
Analysis - Global Forecasts to 2018 " analyzes
and studies the major market drivers, restraints,
and opportunities in North America, Europe, Asia,
and Rest of the World. Browse 14 market data
tables with 29 figures spread through 171 Slides
and in-depth TOC on this report.http//www.market
sandmarkets.com/Market-Reports/aptamers-technology
-market-1167.html Early buyers will receive 10
customization on this report.
3
This report studies the global aptamers market,
with forecast to 2018. The global healthcare
industry is witnessing a paradigm shift, skewed
towards point-of-care diagnostics, cost-effective
treatment modalities, and personalized medicine,
which not only offers efficient early diagnosis,
but also treats serious illnesses in order to
reduce the cost and disease burden. Aptamers is
one such technology with the potential to
revolutionize medical diagnostics and
therapeutics in healthcare. This market research
report evaluates the global market of aptamers by
geography, applications, and aptamer type.
Further, the applications market is divided into
six segments, namely, therapeutics, diagnostics,
biosensors, drug discovery, biomarker discovery,
and research applications. Of the above mentioned
application segments, research applications is
the largest revenue segment however, biomarker
discovery and diagnostics will be the
fastest-growing segment.
4
The global aptamers market was valued at 200
million in the year 2012. At the end of 2013, the
market is expected to be 287 million and is
poised to reach approximately 2.1 billion by
2018, growing at a CAGR of 49.24 from 2013 to
2018. The biomarker discovery, drug discovery
and diagnostics segments offer vast opportunities
for key players in this market. The launch of the
first aptamer drug, Macugen, and the first
diagnostic test for testing mycotoxins in grains
has acknowledged the potential of aptamers in
therapeutics and diagnostics. This scenario is
expected to further revolutionize the industry
towards massive growth in the next 5 to 10
years.
5
The global market for aptamers is expected to
grow, backed by technological advancements with
respect to selection processes and synthesis. The
market will experience continuous improvements in
aptamer synthesis and its applicability in drug
discovery and routine research. The market is
witnessing a trend toward development of
personalized medicine and point-of-care
diagnostic tests. Additionally, the demand for
safe and cost-effective drugs for treatment of
cancer (which can be fulfilled by aptamer
therapeutics), will remarkably fuel market
growth. North America is the largest hub for
aptamers market, accounting for the largest
share, followed by Europe and Asia. North America
and Europe are expected to grow at a steady pace.
However, the Asia-Pacific market, particularly
India and China, is expected to witness a boost
in demand and is poised to register maximum
growth over the next five years, owing to the
increased purchasing power of patients. The key
players in the aptamers market are AM
Biotechnologies, LLC (U.S.), Aptagen, LLC (U.S.),
Aptamer Sciences Inc. (South Korea), Aptamer
Solutions Ltd (U.K.), Base Pair Biotechnologies
(U.S.), Bioapter S.L. (Spain), Integrated
Biotechnologies, Inc. (U.S.), NOXXON Pharma AG
(Germany), OTC Biotech (U.S.), Regado
Biosciences, Inc. (U.S.), Somalogic, Inc. (U.S.),
and TriLink BioTechnologies, Inc. (U.S.).
6
About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.
http//www.marketsandmarkets.com/Market-Reports/ap
tamers-technology-market-1167.html
7
Contact Us
Mr. RohanNorth - Dominion Plaza, 17304 Preston
Road, Suite 800, Dallas, TX 75252Tel
1-888-6006-441Email sales_at_marketsandmarkets.com
 MarketsandMarkets Bloghttp//twitter.com/market
smarkets
http//www.linkedin.com/company/marketsandmarkets
Write a Comment
User Comments (0)
About PowerShow.com